| Literature DB >> 23202905 |
Yong Ye1, Ya Guo, Yue-Ting Luo.
Abstract
Shells are by-products of oil production from Camellia oleifera which have not been harnessed effectively. The purpose of this research is to isolate flavonoid from shells of Camellia oleifera and evaluate its anti-inflammatory and analgesic effects. The flavonoid was identified as bimolecular kaempferol structure by UV, MS, 1H NMR and 13C NMR spectra, which is a new biflavonoid and first found in Camellia oleifera. It showed dose-dependent anti-inflammatory activity by carrageenin-induced paw oedema in rats and croton oil induced ear inflammation in mice, and analgesic activity by hot plate test and acetic acid induced writhing. The mechanism of anti-inflammation of biflavonoid is related to both bradykinin and prostaglandins synthesis inhibition. The biflavonoid showed both central and peripheral analgesic effects different from aspirin, inhibition of the synthesis or action of prostaglandins may contribute to analgesic effect of biflavonoid. The biflavonoid significantly decreased malonaldehyde (MDA) and increased superoxidase dismutase (SOD) and Glutathione peroxidase (GSH-Px) activity in serum (p < 0.01), revealed strong free radical scavenging activity in vivo. It indicates the biflavonoid can control inflammation and pain by eliminating free radical so as to inhibit the mediators and decrease the prostaglandins. The biflavonoid can be used as a prospective medicine for inflammation and pain.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23202905 PMCID: PMC3497279 DOI: 10.3390/ijms131012401
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
1H NMR, 13C NMR and HMBC data of the biflavonoid from shells of Camellia oleifera (DMSO-d6).
| Position | 1H NMR | 13C NMR | HMBC |
|---|---|---|---|
| 2(2″) | 146.8 | ||
| 3(3″) | 135.6 | ||
| 4(4″) | 176.9 | ||
| 5(5″) | 160.7 | ||
| 6(6″) | 6.44 (s) | 98.2 | C-5(5″),7(7″),8(8″),10(10″) |
| 7(7″) | 163.9 | ||
| 8(8″) | 98.2 | ||
| 9(9″) | 156.2 | ||
| 10(10″) | 103.0 | ||
| 1′ (1‴) | 121.6 | ||
| 2′(2‴) | 8.04 (d, | 129.5 | C-1′(1‴),3′(3‴),5′(5‴) |
| 3′(3‴) | 6.93 (d, | 115.4 | C-2′(2‴),4′(4‴),6′(6‴) |
| 4′(4‴) | 159.2 | ||
| 5′(5‴) | 6.93 (d, | 115.4 | C-2′(2‴),4′(4‴),6′(6‴) |
| 6′(6‴) | 8.04 (d, | 129.5 | C-1′(1‴),3′(3‴),5′(5‴) |
| 3-OH(3″-OH) | 10.78 (s, br) | C-2(2″),3(3″),4(4″) | |
| 5-OH(5″-OH) | 12.48 (s, br) | C-5(5″),6(6″),10(10″) | |
| 7-OH(7″-OH) | 10.10 (s, br) | C-6(6″),7(7″),8(8″) | |
| 4′-OH(4‴-OH) | 9.37 (s, br) | C-3′(3‴),4′(4‴),5′(5‴) |
Figure 1Molecular structure of the biflavonoid extracted from shells of Camellia oleifera.
Effect of the biflavonoid on carrageenin-induced paw oedema in rats.
| Drug | Dose (mg/kg, i.g.) | Difference in volume between right paw and left paw in mL Mean ± SD ( | |||
|---|---|---|---|---|---|
|
| |||||
| 0 h | 1 h | 2 h | 4 h | ||
| Normal control | / | 0.14 ± 0.03 | 0.19 ± 0.03 | 0.29 ± 0.04 | 0.53 ± 0.05 |
| Aspirin | 200 | 0.13 ± 0.02 | 0.17 ± 0.03 | 0.21 ± 0.03 | 0.22 ± 0.03 |
| Biflavonoid | 50 | 0.15 ± 0.04 | 0.18 ± 0.04 | 0.24 ± 0.04 | 0.36 ± 0.05 |
| Biflavonoid | 100 | 0.15 ± 0.04 | 0.17 ± 0.04 | 0.24 ± 0.04 | 0.28 ± 0.05 |
| Biflavonoid | 200 | 0.12 ± 0.02 | 0.16 ± 0.02 | 0.21 ± 0.03 | 0.21 ± 0.02 |
Data were analyzed by ANOVA and Dunnett’s test.
Denotes significant inhibition as compared to normal control (p < 0.01).
Effect of the biflavonoid on croton oil induced ear inflammation in mice.
| Drug | Dose (mg/kg, i.g.) | Difference in weight between left and right punched ear in mg Mean ± SD ( | Inhibition (%) |
|---|---|---|---|
| Normal control | / | 36.1 ± 9.3 | / |
| Aspirin | 200 | 11.0 ± 5.0 | 69.5 |
| Biflavonoid | 50 | 24.5 ± 4.6 | 32.2 |
| Biflavonoid | 100 | 18.6 ± 4.4 | 48.6 |
| Biflavonoid | 200 | 10.2 ± 3.6 | 71.9 |
Data were analyzed by ANOVA and Dunnett’s test.
Denotes significant inhibition as compared to normal control (p < 0.01).
Figure 2Inhibition of pain threshold in hot plate test of mice by different treatment. Values represent means ± SD (n = 8).
Inhibition on acetic acid induced writhing in mice by the biflavonoid.
| Drug | Dose (mg/kg, i.g.) | Number of writhing Mean ± SD ( | Inhibition (%) |
|---|---|---|---|
| Normal control | / | 72.6 ± 7.6 | / |
| Aspirin | 200 | 22.6 ± 4.6 | 68.8 |
| Biflavonoid | 50 | 57.2 ± 9.0 | 21.2 |
| Biflavonoid | 100 | 48.5 ± 6.5 | 33.2 |
| Biflavonoid | 200 | 33.4 ± 5.7 | 54.0 |
Data were analyzed by ANOVA and Dunnett’s test.
Denotes significant inhibition as compared to normal control (p < 0.01).
Effect of the biflavonoid on malonaldehyde (MDA), superoxidase dismutase (SOD) and Glutathione peroxidase (GSH-Px) activities in blood of rats.
| Groups | Dose (mg/kg) | MDA (nmol/mL) | SOD (U/mL) | GSH-Px (U/mL) |
|---|---|---|---|---|
| Normal control | 6.11 ± 0.47 | 61.62 ± 7.92 | 41.32 ± 8.54 | |
| Aspirin | 200 | 5.42 ± 0.77 | 60.59 ± 5.27 | 48.08 ± 7.33 |
| Biflavonoid | 50 | 5.47 ± 0.96 | 59.20 ± 7.66 | 52.53 ± 8.12 |
| Biflavonoid | 100 | 4.70 ± 0.88 | 67.36 ± 6.32 | 56.62 ± 8.76 |
| Biflavonoid | 200 | 3.70 ± 0.92 | 75.43 ± 5.95 | 78.12 ± 8.79 |
Each value was expressed as mean ± standard deviation (n = 6), data were analyzed by ANOVA and Dunnett test.
Significant difference at p < 0.01, compared with normal control.